Global MedTech Healthcare IT Industry Competitive Landscape

Report Scope:
This report incorporates an in-depth analysis of the MedTech market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines major players’ recent developments and product portfolios, along with market share analysis and ranking in the market. Regulatory landscape analysis focuses on recent regulations in the U.S., Europe and Japan. The MedTech industry scope includes the medical device industry, IVD diagnostics and the Healthcare IT industry (AI, digital health, blockchain, etc.).

Report Includes:
- 29 data tables and 77 additional tables
- An updated assessment of the global MedTech market and industry competitive landscape
- Discussion of current and future demand in the global MedTech industry, along with a detailed analysis of the competitive environment, market regulations, and reimbursement practices
- Review of patents granted on medical technology by each major category, and emerging developments in the global MedTech market
- Identification of the companies best positioned to meet the increasing demand for medical device industry, IVD diagnostics, and the Healthcare IT industry owing to their proprietary technologies, M&A deals, new developments and other growth strategies
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, and COVID-19 implications on the progress of this market
- Market share analysis of the key market participants in the MedTech industry, along with their research priorities, product portfolios, global rankings, and company competitive landscape
- Company profiles of major players, including Cardinal Health Inc., McKesson, Microsoft, General Electric Co. (GE), Johnson & Johnson Services Inc., Hitachi Medical Corp.

 

Summary:
The MedTech market is benefitting from the adoption of innovative technologies (artificial intelligence [AI], machine learning [ML] and deep learning [DL]). New technologies enhance the quality and productivity of diagnosis and treatment. This report includes extensive competitive landscapes, patent analyses, startup ecosystem evaluation, recent developments, innovations and other factors that provide insights into the MedTech market. BCC Research will provide an overview of the current and future characteristics of the global market for MedTech. The report also highlights various government regulations and policies, research and development (R&D), exploration and government programs to predict market trends and the scope of the MedTech market. This report explores present and future strategies influencing the MedTech market and the market outlook, including its setbacks and opportunities.

Reasons for Doing This Study:

Longer life expectancy and emerging economies increase expenditure on healthcare; there is an increased demand for technologically-superior medical technology. More stringent regulations, specifically in the U.S. and European (mature) markets, compel medical device manufacturers to launch sophisticated devices that incorporate new materials, focus on in-depth indications and generate additional data.

Technically-sophisticated medical technology is needed for clinical research. The market is highly competitive and companies must constantly reinvent product portfolios in order to enter new markets and gain position in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This results in increased scrutiny of technology. The degree of competition has risen.

The above reasons are compelling enough to research and analyze the medical technology market. The market has tremendous growth potential.

 

Companies Mentioned 

3M
ABBOTT LABORATORIES
ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
ATHENAHEALTH
B. BRAUN MELSUNGEN AG
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES INC.
BIOMÉRIEUX SA
BOSTON SCIENTIFIC CORP.
CANON MEDICAL SYSTEM CORP.
CARDINAL HEALTH INC.
CERNER CORP.
COCHLEAR AMERICAS
COGNIZANT
DANAHER
Edward Lifesciences Corp.
EPIC SYSTEMS CORP.
FUJIFILM HOLDING CORP.
GE HEALTHCARE
HITACHI LTD.
HOLOGIC INC.
INTEL CORP.
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
JOHNSON & JOHNSON SERVICES INC.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
MCKESSON CORP.
MEDTRONIC PLC
MICROSOFT CORP.
NANO-X IMAGING LTD.
OLYMPUS CORP.
PHILIPS HEALTHCARE
ROCHE HOLDING AG
SAMSUNG ELECTRONICS INC.
SIEMENS HEALTHCARE
SMITH & NEPHEW PLC
STRYKER CORP.
TERUMO CORP.
UNITEDHEALTH GROUP
ZOLL MEDICAL CORP.

 


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Market and Technology Background
Evolution
Future of Medical Technology
Healthcare IoT Market
Blockchain in Healthcare
3D Printing
Artificial Intelligence in Healthcare
Reimbursement Practices
United States
Europe
Japan
RoW
FDA-Approved AI and ML-Enabled Medical Devices
Chapter 3 Impact of COVID-19
Overview
Decline/Delay in Elective Procedures
Supply Chain Disruptions
Strong Impact in China
Impact of COVID 19 on Medical Device Product Segments
Home-Based Pathology
Chapter 4 Regulatory Framework and Guidelines

Regulatory Framework for Medical Devices
Code of Federal Regulations (CFR)
Premarket Notification 510(k) Clearance to Market
510 (k) Exempt Devices
PMA (Pre-Market Approval)
Good Manufacturing Compliance (GMP) Compliance
Establishment Registration
Device Registration and Listing
Labelling Requirement
Medical Device Reporting (MDR)
Local Agent Requirements
Medical Device User Fee
European Union (EU)
Japan
Regulations for Healthcare IT
Certification Commission for Healthcare Information Technology
Federal Legislation
Better Healthcare Through Information Technology Act of 2005
Medicare Value Purchasing Act
Health Information Technology Promotion Act
Wired for Healthcare Quality Act
American Recovery and Reinvestment Act of 2009
Patient Protection and Affordable Care Act of 2010
Continuing Extension Act of 2010
Electronic Health Records Improvement Act of 2012
Food and Drug Administration Safety and Innovation Act
Healthcare IT Regulatory Schemes in China
Regulatory Scenario of Healthcare IT in Singapore
EU Approach to Regulation
Regulatory Framework for Telemedicine
American Diabetes Associations Standards of Medical Care in Diabetes
ATA Guidelines for Artificial Intelligence (AI)
Indian AI Guidelines, Strategy and Standards
Chapter 5 Patent Review
Introduction
Patent Review by Company
IBM
Other Major Players
Patent Review by Geography
Chapter 6 Start-up Ecosystem
Introduction
Chapter 7 Competitive Landscape Analysis
Primary Strategies: Product Launch
Strategic Review by Company
Market Share Analysis
Market Share of IVD Industry
Market Share of Healthcare IT
Chapter 8 Company Profiles
3M
ABBOTT LABORATORIES
ALLSCRIPTS HEALTHCARE SOLUTIONS INC.
ATHENAHEALTH
B. BRAUN MELSUNGEN AG
BECTON, DICKINSON AND CO.
BIOMÉRIEUX SA
BIO-RAD LABORATORIES INC.
BOSTON SCIENTIFIC CORP.
CARDINAL HEALTH INC.
CANON MEDICAL SYSTEM CORP.
CERNER CORP.
COCHLEAR AMERICAS
COGNIZANT
DANAHER
EDWARD LIFESCIENCES CORP.
EPIC SYSTEMS CORP.
FUJIFILM HOLDING CORP.
GE HEALTHCARE
HITACHI LTD.
HOLOGIC INC.
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
INTEL CORP.
JOHNSON & JOHNSON SERVICES INC.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
MCKESSON CORP.
MEDTRONIC PLC
MICROSOFT CORP.
NANO-X IMAGING LTD.
OLYMPUS CORP.
PHILIPS HEALTHCARE
ROCHE HOLDING AG
SAMSUNG ELECTRONICS INC.
SIEMENS HEALTHCARE
SMITH & NEPHEW PLC
STRYKER CORP.
TERUMO CORP.
UNITEDHEALTH GROUP
ZOLL MEDICAL CORP.

 


List Of Tables


Table 1 : FDA-Cleared AI Medical Products, Radiology and Other Imaging Modalities, U.S., 2018-2021
Table 2 : Class I and Class II Devices Exempted from Premarket Approval
Table 3 : Medical Device User Fee Amendments (MDUFA): 2020
Table 4 : Regulatory Approval: U.S. Versus Europe
Table 5 : Global Regulatory Framework, Telemedicine, by Country
Table 6 : Patents Granted to IBM, 2022-Present
Table 7 : Other Patents Granted to Major Market Players, 2022
Table 8 : Start-ups, Global MedTech Market, 2015-2021
Table 9 : Major Market Strategies, Global MedTech Market, 2019-2022
Table 10 : Products Launched, Medical Technology, by Key Market Player, 2019-2022
Table 11 : 3M: Products and Services
Table 12 : 3M: Company Financials, 2019
Table 13 : 3M: Recent Developments, 2015-2020
Table 14 : Abbott: Product Portfolio
Table 15 : Abbott: Recent Developments, 2021 and 2022
Table 16 : Allscripts Healthcare Solutions Inc.: Products
Table 17 : Allscripts Healthcare Solutions Inc.: Financials, 2018-2020
Table 18 : Allscripts Healthcare Solutions Inc.: Recent Developments, 2020-2022
Table 19 : Athenahealth: Product Portfolio
Table 20 : Athenahealth: Recent Developments, 2021 and 2022
Table 21 : B. Braun Melsungen AG: Product Description
Table 22 : B. Braun Melsungen AG: Company Financials, 2018
Table 23 : Becton, Dickinson and Co.: Company Financials, 2019
Table 24 : Beckton, Dickinson and Co.: Product Portfolio
Table 25 : Beckton, Dickinson and Co.: Recent Developments, 2020-2022
Table 26 : bioMérieux: Products and Services
Table 27 : bioMérieux: Recent Developments, 2018-2020
Table 28 : Bio-Rad Laboratories: Company Financials, 2019
Table 29 : Bio-Rad Laboratories: Products and Services
Table 30 : Bio-Rad Laboratories: Recent Developments, 2018-2020
Table 31 : Boston Scientific Corp.: Recent Developments, 2020 and 2021
Table 32 : Cardinal Health: Product Portfolio
Table 33 : Cardinal Health: Company Financials, 2019
Table 34 : Cardinal Health: Recent Developments, 2013-2019
Table 35 : Canon Medical System: Company Financials, 2019-2021
Table 36 : Canon Medical System: Product Portfolio
Table 37 : Canon Medical System: Strategies and Developments, 2020 and 2021
Table 38 : Cerner Corp.: Product Portfolio
Table 39 : Cerner Corp.: Financial Performance, 2018-2020
Table 40 : Cerner Corp.: Strategies and Developments, 2019-2022
Table 41 : Cognizant: Healthcare Technology Solutions
Table 42 : Cognizant: Financial Performance, 2018-2020
Table 43 : Danaher: Product Portfolio
Table 44 : Danaher: Company Financials, 2019
Table 45 : Danaher: Products and Services
Table 46 : Danaher: Recent Developments, 2015-2020
Table 47 : Edward LifeSciences Corp.: Company Financials, 2019
Table 48 : Edwards Lifesciences Corp.: Revenue, by Product Segment, 2018 and 2019
Table 49 : Edward LifeSciences Corp.: Recent Developments, 2017-2019
Table 50 : Epic Systems Corp.: Solutions
Table 51 : Fujifilm Holding: Company Financials, 2020 and 2021
Table 52 : Fujifilm Holding Corp.: Product Portfolio
Table 53 : Product Portfolio
Table 54 : Fujifilm Holding Corp.: Strategies and Developments, 2019 and 2020
Table 55 : GE: Financial Performance, 2019 and 2020
Table 56 : GE Healthcare: Product Portfolio
Table 57 : GE Healthcare: Strategies and Developments, 2019-2022
Table 58 : Hitachi Medical Corp.: Products and Services
Table 59 : Hitachi Medical Corp.: Company Financials, 2019
Table 60 : Hitachi Medical Corp.: Key Developments and Strategies, 2016-2020
Table 61 : Hologic Inc.: Company Financials, 2019
Table 62 : Hologic Inc.: Developments and Strategies, 2017-2020
Table 63 : IBM Corp.: Company Financials, 2019 and 2020
Table 64 : IBM Corp.: Product Portfolio
Table 65 : IBM Corp.: Strategies and Developments, 2018-2021
Table 66 : Intel Corp.: Product Portfolio
Table 67 : Intel Corp.: Company Financials, 2019 and 2020
Table 68 : Johnson & Johnson: Company Financials, 2019
Table 69 : Johnson & Johnson: Product Description
Table 70 : Johnson & Johnson: Recent Developments and Strategies, 2017 and 2018
Table 71 : McKesson Corp.: Business Segment
Table 72 : McKesson Corp.: Financial Performance, 2017-2020
Table 73 : Medtronic plc: Product Portfolio
Table 74 : Medtronic plc: Patient Monitoring Device Product Portfolio
Table 75 : Medtronic plc: Strategies and Developments, 2019-2021
Table 76 : Microsoft Corp.: Company Financials, 2019 and 2020
Table 77 : Microsoft Corp.: Product Portfolio
Table 78 : Microsoft Corp.: Strategies and Developments, 2019-2021
Table 79 : Nano-X AI: Product Portfolio
Table 80 : Nano-X AI: Strategies and Developments, 2020 and 2021
Table 81 : Nano-X AI: MSaaS Agreements, 2020
Table 82 : Olympus Corp.: Product Portfolio
Table 83 : Olympus Corp.: Company Financials, 2019
Table 84 : Olympus Corp.: Recent Developments, 2016-2020
Table 85 : Phillips Healthcare: Company Financials, 2019 and 2020
Table 86 : Philips Healthcare: Product Portfolio, AI in Diagnostics
Table 87 : Phillips Healthcare: Strategies and Developments, 2020 and 2021
Table 88 : F. Hoffmann-La Roche Ltd.: Company Financials, 2019 and 2020
Table 89 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019 and 2020
Table 90 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 91 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2020-2022
Table 92 : Samsung Electronics Inc.: Product Portfolio
Table 93 : Samsung Electronics Inc.: Strategic Developments, 2021
Table 94 : Siemens Healthcare GmbH: Product Segments
Table 95 : Siemens Healthcare GmbH: Products
Table 96 : Siemens Healthcare GmbH: Company Financials, 2020 and 2021
Table 97 : Siemens Healthcare GmbH: Key Developments
Table 98 : Smith & Nephew plc: Company Financials, 2019
Table 99 : Smith & Nephew plc: Product Portfolio
Table 100 : Smith & Nephew plc: Recent Developments, 2015-2017
Table 101 : Stryker Corp.: Product Description
Table 102 : Terumo Corp.: Company Financials, 2019
Table 103 : Terumo Corp.: Recent Developments, 2020
Table 104 : UnitedHealth Group: Businesses
Table 105 : UnitedHealth Group: Financial Performance, 2018-2020
Table 106 : Zoll Medical Corp.: Product Portfolio

 


List Of Figures


Figure 1 : FDA-Approved AI Medical Products, Radiology and Other Imaging, U.S., by Modality, 2018-2021
Figure 2 : Share of FDA-Approved AI Algorithms, Diagnostics, U.S., by Company, 2018-2021
Figure 3 : Patents Granted to IBM, 2021 and 2022
Figure 4 : Patents Granted to Other Major Players, 2019-2021
Figure 5 : Share of Patents Granted in MedTech, by Country, 2021-2022
Figure 6 : Start-ups, MedTech Industries, by Country, 2000 and 2021
Figure 7 : Key Strategies, by Market Players During, 2019-2022
Figure 8 : Key Strategies, by Company, 2018-2021
Figure 9 : Number of Strategic Actions, by Company, 2018-2021
Figure 10 : Global Market Share Analysis, IVD Industry, by Key Companies, 2021
Figure 11 : Global Market Share Analysis, Healthcare IT, by Key Company 2021
Figure 12 : 3M: Revenue, by Business Segment, 2019
Figure 13 : 3M: Revenue, by Region, 2019
Figure 14 : Abbott: Annual Revenue, 2018-2021
Figure 15 : Abbott: Vascular Business Annual Revenue, 2018-2021
Figure 16 : Abbott: Revenue, by Country, 2021
Figure 17 : Allscripts Healthcare Solutions Inc.: Revenue, by Business Segment, 2020
Figure 18 : Allscripts Healthcare Solutions Inc.: Revenue, by Region, 2020
Figure 19 : Boston Scientific Corp.: Annual Revenue, 2018-2021
Figure 20 : Boston Scientific Corp.: Revenue, by Business Segment, 2021
Figure 21 : Boston Scientific Corp.: Revenue, by Region, 2021
Figure 22 : Cerner Corp.: Revenue, by Business Model, 2020
Figure 23 : Cerner Corp.: Revenue, by Region, 2020
Figure 24 : Cognizant: Revenue, by Business Segment, 2020
Figure 25 : Cognizant: Revenue, by Region, 2020
Figure 26 : Danaher: Revenue, by Segment, 2019
Figure 27 : Danaher: Revenue, by Region, 2019
Figure 28 : Edwards LifeSciences Corp.: Revenue, by Segment, 2019
Figure 29 : Edwards LifeSciences Corp.: Revenue, by Region, 2019
Figure 30 : GE: Revenue, by Business Segment, 2020
Figure 31 : GE Healthcare: Revenue, by Region, 2020
Figure 32 : Hitachi Medical Corp.: Revenue, by Region, 2019
Figure 33 : Hitachi Medical Corp.: Revenue, by Business Segment, 2019
Figure 34 : Hitachi Medical Corp.: Revenue, by Smart Life Sub-Segment, 2019
Figure 35 : Hologic Inc. Annual Revenue, 2014-2019
Figure 36 : Hologic Inc.: Revenue, by Region, 2019
Figure 37 : Hologic Inc.: Revenue, by Segment, 2019
Figure 38 : IBM Corp.: Revenue, by Business Segment, 2020
Figure 39 : Intel Corp.: Revenue, by Region, 2020
Figure 40 : Johnson & Johnson: Annual Revenue, 2017-2019
Figure 41 : Johnson & Johnson: Revenue, by Region, 2019
Figure 42 : Johnson & Johnson: Revenue, by Segment, 2019
Figure 43 : McKesson Corp.: Revenue, by Business Segment, 2020
Figure 44 : McKesson Corp.: Revenue, by Region, 2020
Figure 45 : Medtronic plc: Annual Revenue, 2018-2021
Figure 46 : Medtronic plc: Coronary and Peripheral Vascular Segment, Annual Revenue, 2019-2021
Figure 47 : Medtronic plc: Revenue, by Region, 2021
Figure 48 : Microsoft Corp.: Revenue, by Region, 2020
Figure 49 : Olympus Corp.: Revenue, by Business Segment, 2019
Figure 50 : Olympus Corp.: Revenue, by Region, 2019
Figure 51 : Phillips Healthcare: Revenue, by Region, 2020
Figure 52 : F. Hoffmann-La Roche Ltd.: Revenue, by Business Segment, 2019
Figure 53 : F. Hoffmann-La Roche Ltd.: Revenue, by Region/Country, 2019
Figure 54 : Siemens Healthcare GmbH: Revenue, by Business Segment, 2020
Figure 55 : Siemens Healthcare GmbH: Revenue, by Region, 2019
Figure 56 : Smith & Nephew plc: Revenue, by Business Segment, 2019
Figure 57 : Smith & Nephew: Revenue, by Region, 2019
Figure 58 : Terumo Corp.: Revenue, by Segment, 2018
Figure 59 : Terumo Corp.: Revenue, by Region, 2018
Figure 60 : UnitedHealth Group: Revenue, by Business Segment, 2020

 


2022-2026 Global Cancer Diagnostics Market in the USA, Europe, Japan--Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers

This unique database from LeadingMarketResearch.com provides information and analysis not available from any other published source, including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers.

USD 9500 View Report

2021-2026 Global Blood Typing, Grouping and Infectious Disease NAT Screening Market--USA, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and

USD 14500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available

 

 

FAQs

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.